港股異動 | 濠賭股拉昇 輝瑞新冠藥物療效顯著
格隆匯11月8日丨濠賭股集體拉昇上揚,金沙中國漲近6%,美高梅中國、銀河娛樂、澳博控股、永利澳門皆漲超4%。上週五,輝瑞宣佈其新冠口服藥物Paxlovid減少新冠肺炎非住院患者的住院或死亡率高達89%,數據顯著優於默沙東的Molnupiravir。受疫情影響的濠股今日聞聲大漲。市場人士認為,短期來看,疫苗的進展突破對旅遊等市場有一定帶動,長期看市場仍受疫情影響,下一步主要關注點仍在簽註政策及港澳通關政策。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.